Home › Funds › D. E. Shaw & Co › ALLO
D. E. Shaw & Co position in ALLO
ALLOGENE THERAPEUTICS INC COM · Health Care
Latest position (Q2 2026)4.71M sh
Reported value held$9.80M
Portfolio Weight0.01%
First reportedQ3 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 463.90K | $575.23K | New |
| Q4 2025 | 1.28M | $1.76M | Add |
| Q1 2026 | 2.76M | $6.74M | Add |
| Q2 2026 | 4.71M | $9.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALLO
- BlackRock Inc 30.15M sh · $62.71M · Q2 2026
- PFIZER INC 22.03M sh · $46.93M · Q2 2026
- Frazier Life Sciences Management, L.P. 22.45M sh · $46.69M · Q2 2026
- TPG GP A, LLC 18.72M sh · $38.93M · Q2 2026
- Sio Capital Management, LLC 13.32M sh · $27.71M · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 13.12M sh · $27.30M · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 12.17M sh · $25.31M · Q2 2026
- Fidelity Management & Research (FMR) 12.01M sh · $24.98M · Q2 2026
- Two Sigma Investments 7.78M sh · $16.19M · Q2 2026
- Geode Capital Management 7.05M sh · $14.67M · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 7.05M sh · $14.67M · Q2 2026
- Goldman Sachs Group 6.15M sh · $12.79M · Q2 2026